Patient recruitment: improving access to patients
Recruiting patients is often, if not always, the most expensive and time consuming part of a clinical trial. For oncology drug development the problem is particularly pronounced.
This presentation will focus on new techniques to improve access to the right patients geographical expansion.
Constance K. Wierman, Nick Taylor
Constance K. Wierman
Ms. Wierman joined INC Research in 2005. She has nearly 25 years of experience in the biopharmaceutical industry, inclusive of 10 years specific to the CRO sector. She has held positions of increasing responsibility within the CRO environment, with an emphasis on clinical development of oncology therapies on a global basis. Her experience includes a breadth of key business support positions in the medical device and pharmaceutical sectors of healthcare. She started her career in marketing of Class 3 medical devices for St. Jude Medical, Inc and Baxter HealthCare, then moved into pharmaceutics for Fujisawa; she has significant product launch experience in both sectors. She also has business development experience in the service sector, building a business base among biotechnology and pharmaceutical companies in the oncology arena for ILEX Oncology, Inc. Prior to joining INC, Ms. Wierman was responsible for developing and leading a team of Medical Science Liaisons in the United States for ILEX (now Genzyme) to support the research and educational goals for use of oncology agents under development and newly launched. Prior to her move to industry, Ms. Wierman had six years bench research experience in academia including pharmaceutical biochemistry and medical chemistry.
Nick Taylor is science reporter covering the global contract services sector for Outsourcing-Pharma. He has a BSc in biology from the University of York and certification from the National Council for the Training of Journalists. Nick lives and works in the south of France.